Chloroquine Phosphate Prices March 2024
Product
|
Category |
Region |
Price |
Chloroquine Phosphate |
Pharma API |
Madagascar |
92,000 USD/Ton |
The price of chloroquine phosphate in Madagascar for Q1 2024 reached 92,000 USD/Ton in March.
Chloroquine Phosphate Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Chloroquine Phosphate Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of chloroquine phosphate pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot price of chloroquine phosphate at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of chloroquine phosphate price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing chloroquine phosphate price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
Chloroquine Phosphate Market Analysis
The global chloroquine phosphate market size reached US$ 131.6 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 44.5 Million, at a projected CAGR of -11.40% during 2023-2032.
- Chloroquine phosphate, a well-known antimalarial drug, has gathered significant attention due to the persistent global burden of malaria, particularly in tropical and subtropical regions, which continues to drive the demand for effective antimalarial treatments. Besides resistance issues, chloroquine remains a crucial part of malaria treatment strategies in certain regions, which is contributing to the market growth.
- The growing emphasis on research and development (R&D) in the pharmaceutical sector is strengthening the market growth. Increased funding and research into the broader applications of chloroquine, such as its potential anti-inflammatory and antiviral properties, have opened new avenues for its use beyond traditional malaria treatment.
- Moreover, the rising prevalence of autoimmune diseases like rheumatoid arthritis and lupus has influenced the market growth, spurring its use as an off-label treatment for these conditions due to its immunomodulatory effects. Consequently, as awareness and diagnosis of autoimmune diseases increase, so does the demand for effective treatments, including chloroquine phosphate.
- Furthermore, the pharmaceutical industry's shift towards generic drug production has impacted the chloroquine market. Generic manufacturers have ramped up production to meet the increasing demand, making the drug more accessible and affordable, particularly in developing countries, thus creating a positive outlook for market expansion.
- Supply chain dynamics also play a significant role in shaping the chloroquine phosphate market. The COVID-19 pandemic exposed vulnerabilities in the global pharmaceutical supply chain, prompting efforts to strengthen and diversify sources of active pharmaceutical ingredients (APIs). This has led to increased investment in domestic manufacturing capabilities and partnerships to ensure a stable supply of chloroquine phosphate, thereby bolstering the market growth.
- Additionally, regulatory support and policies aimed at improving access to essential medicines have positively influenced the market growth. Governments and health organizations are working to ensure that chloroquine phosphate remains available and affordable for those who need it, particularly in malaria-endemic regions, thus fostering market expansion.
- Apart from this, the emerging trend towards digital health and telemedicine facilitating broader access to chloroquine phosphate is providing an impetus to the market growth. Telemedicine platforms have enabled patients in remote or underserved areas to receive prescriptions and treatment guidance, thereby propelling the market growth.
Chloroquine Phosphate News
The report covers the latest developments, updates, and trends impacting the global chloroquine phosphate market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in chloroquine phosphate production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the chloroquine phosphate price trend.
Latest developments in the chloroquine phosphate industry:
- July 2024: Brazil and Thailand have launched a new single-dose radical cure medicine, tafenoquine co-administered with chloroquine, to prevent the relapse of Plasmodium vivax malaria. This is a significant step towards eliminating malaria in these countries. Tafenoquine targets the liver-stage of the parasite, providing a more effective treatment compared to the previous 7-14 day regimen of primaquine. The launch of this new treatment option, with point-of-care G6PD testing, will help address the challenges faced by vulnerable communities disproportionately affected by malaria.
Product Description
Chloroquine phosphate is a medication primarily used as an antimalarial agent. It is formulated in tablet form and has been a cornerstone in the fight against malaria for decades. Chloroquine phosphate functions by inhibiting the parasite's ability to detoxify itself, effectively killing the malaria-causing organisms. It is particularly effective against Plasmodium vivax, P. malariae, and susceptible strains of P. falciparum.
Chloroquine phosphate is administered to patients either as a prophylactic measure for those traveling to malaria-endemic areas or as a treatment for individuals who have contracted malaria. Its role in malaria control is crucial, especially in regions where the disease is rampant.
Besides its well-known application in malaria treatment, chloroquine phosphate has been explored for various other medical uses. It has demonstrated potential in treating autoimmune diseases such as rheumatoid arthritis and lupus erythematosus due to its anti-inflammatory properties.
Regional Coverage
The report provides a detailed analysis of the chloroquine phosphate market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the chloroquine phosphate price trend.
Global Chloroquine Phosphate Price
The report offers a holistic view of the global chloroquine phosphate pricing trends in the form of chloroquine phosphate price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of chloroquine phosphate but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.
The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed chloroquine phosphate demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Chloroquine Phosphate Price
European chloroquine phosphate prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.
This analysis can be extended to include detailed chloroquine phosphate price information for a comprehensive list of countries.
Region |
Countries Covered |
Europe |
Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Chloroquine Phosphate Price
The analysis of chloroquine phosphate prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.
Specific chloroquine phosphate historical data within the United States and Canada can also be provided.
Region |
Countries Covered |
North America |
United States and Canada |
Middle East and Africa Chloroquine Phosphate Price
The report explores the chloroquine phosphate pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on chloroquine phosphate prices for countries can also be provided.
Region |
Countries Covered |
Middle East & Africa |
Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Chloroquine Phosphate Price
The chloroquine phosphate pricing trends in the Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.
This chloroquine phosphate price analysis can be expanded to include a comprehensive list of countries within the region.
Region |
Countries Covered |
Asia Pacific |
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Chloroquine Phosphate Price
The analysis of chloroquine phosphate prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
Region |
Countries Covered |
Latin America |
Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
Key Attributes |
Details |
Product Name |
Chloroquine Phosphate |
Report Features |
Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Chloroquine Phosphate Price Analysis, and Segment-Wise Assessment. |
Currency/Units |
US$ (Data can also be provided in local currency) or Metric Tons |
Region/Countries Covered |
The current coverage includes analysis at the global and regional levels only.
Based on your requirements, we can also customize the report and provide specific information for the following countries:
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*
*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
Information Covered for Key Suppliers |
- Company Overview
- Business Description
- Product Portfolio
- Recent Trends and Developments
|
Customization Scope |
The report can be customized as per the requirements of the customer |
Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
- Scope
- Historical Data for the Current Month
- Forecast for Next Month
- Total Deliverables Per Year: 12 (One Per Month)
- Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year
Plan B: Quarterly Updates - Annual Subscription
- Scope
- Historical Data for the Current Quarter
- Forecast for Next Quarter
- Total Deliverables Per Year: 4 (One Per Quarter)
- Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year
Plan C: Biannually Updates - Annual Subscription
- Scope
- Historical Data for the Current Half
- Forecast for the Next Half
- Total Deliverables Per Year: 2 (One Per 6 Months)
- Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
|
Post-Sale Analyst Support |
360-degree analyst support after report delivery |
Delivery Format |
PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of chloroquine phosphate pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting chloroquine phosphate price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The chloroquine phosphate price charts ensure our clients remain at the forefront of the industry.